Laboratorios Farma | ROVI - Net Income

Stock Price
80.70
Daily Change
-0.40 -0.49%
Monthly
1.13%
Yearly
57.62%
Q2 Forecast
79.04

Laboratorios Farma reported EUR103.69M in Net Income for its fiscal semester ending in December of 2023.





Net Income Change Date
Akebia Therapeutics USD -12.24M 12.78M Dec/2025
Alaunos Therapeutics USD -1.16M 108K Sep/2025
Almirall EUR 19.58M 7M Dec/2025
Avita Medical AUD -11.62M 1.7M Dec/2025
Dianthus Therapeutics USD -64.43M 27.67M Dec/2025
Ionis Pharmaceuticals USD -229M 100.39M Dec/2025
IQVIA Holdings USD 514M 183M Dec/2025
Laboratorios Farma EUR 103.69M 37.04M Dec/2023
Moderna USD -200M 625M Sep/2025
Organon & Co USD 160M 15M Sep/2025
Pharma Mar EUR 59.66M 63.76M Dec/2025
Revvity USD 98.36M 51.71M Dec/2025
Tectonic Therapeutic USD -19.23M 186K Dec/2025
Viatris USD -340.1M 211.9M Dec/2025
Xeris Pharmaceuticals USD 11.08M 10.46M Dec/2025